ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.

These guidelines basically remind us that we should focus on life style changes to best prevent heart disease, heart failure and atrial fibrillation. These changes, of course, should be permanent.

ACC 2019 | Las nuevas guías de prevención primaria ACC/AHA con foco en estilo de vida, dieta y factores socioeconómicos.It is estimated that life style changes translate into 80% risk reduction of heart disease.

 

These recommendations are based on 9 topics: risk estimation, diet, physical activity, obesity, diabetes, cholesterol, hypertension, giving up smoking and the use of aspirin.

 

Social factors have been one of the most difficult fronts and the one with most impact. Physicians seldom show concern about whether patients can afford the drugs we prescribe, or whether they will be able to follow a healthy diet.


Read also: ACC 2019 | SAFARI: Unexpectedly, Radial Approach Offers No Benefits In STEMI.


Moreover, we should routinely try to detect psychosocial stressors and support our patients with savvy advice.

 

For adults between 40 and 75, we recommend screening for traditional risk factors and estimating cardiovascular risk at 10 years (recommendation class I).

 

For patients between 20 and 39, it is reasonable to assess risk factors every 4 to 6 years (recommendation class IIa).


Read also: ACC 2019 | POET: Oral Antibiotics with Good Long-Term Results for Endocarditis.


Patients presenting intermediate or border risk could be better stratified with other markers such as family history, metabolic syndrome, chronic kidney disease, or C-reactive protein.

 

Guidelines also suggest consuming more vegetables, fruits, legumes, whole grains and fish, as well as warning against the consumption of salt, fired foods, processed meats and sugary drinks.

 

They recommend 150 minutes of moderate activity (walking, swimming, cycling) or 75 minutes of a more vigorous activity, and if neither were possible, at least 10 minutes can make a significant difference.


Read also: ACC 2019 | Having an Infarction at Very Young Age or 10 Years Later Does Not Change Long-Term Mortality.


As regards aspirin, it is not recommended as primary prevention in >70-year individuals, or with increased bleeding risk (recommendation class III). For individuals between 40 and 70, aspirin can be considered if there is high cardiovascular risk or low bleeding risk (recommendation class IIb). For most patients, aspirin is not indicated as primary prevention.

 

Original title: 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.

Reference: Arnett DK et al. Circulation 2019; Epub ahead of print.

 

Guias-de-prevención-primaria


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...